Please use this identifier to cite or link to this item:
|Title:||Targets and Patented Drugs for Chemotherapy of Chagas Disease in the Last 15 Years-Period||Authors:||Duschak, Vilma G||Keywords:||Trypanosoma Cruzi;Enfermedad de Chagas;objetivos de drogas;Patente||Issue Date:||2016||Journal:||Recent patents on anti-infective drug discovery||Abstract:||
The American trypanosomiasis, Chagas disease, is a parasitic infection typically spread by triatomine vectors affecting millions of people all over Latin America. Existing chemotherapy is centered on the nitroaromatic compounds benznidazole and nifurtimox that provide unsatisfactory results and substantial side effects. So, the finding and exploration of novel ways to challenge this neglected disease is a main priority.
|Appears in Collections:||Publicaciones INP|
Show full item record
checked on Jul 4, 2020
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.